ShockWave Medical Inc. (SWAV)
334.75
-0.08 (-0.02%)
At close: May 30, 2024, 8:00 PM
-0.02% (1D)
| Bid | n/a |
| Market Cap | 12.57B |
| Revenue (ttm) | 787.97M |
| Net Income (ttm) | 163.5M |
| EPS (ttm) | 4.25 |
| PE Ratio (ttm) | 78.76470588235294 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 3,947,054 |
| Avg. Volume (20D) | 1,246,461 |
| Open | 334.85 |
| Previous Close | 334.83 |
| Day's Range | 334.75 - 334.90 |
| 52-Week Range | 157.00 - 334.90 |
| Beta | 0.88 |
About SWAV
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee ...
Industry Medical - Devices
Sector Healthcare
IPO Date Mar 7, 2019
Employees 1,468
Stock Exchange NASDAQ
Ticker Symbol SWAV
Website https://www.shockwavemedical.com